1. |
Hernández-Pacheco G, Flores-Domínguez C, Rodríguez-Pérez JM, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun, 2003, 21(1):59-63.
|
2. |
Kim L, Kim do K, Yang WI, et al. Overexpression of transforming growth factor-beta 1 in the valvular fibrosis of chronic rheumatic heart disease. J Korean Med Sci, 2008, 23(1):41-48.
|
3. |
Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis, 2005, 5(11):685-694.
|
4. |
Rojas A, Padidam M, Cress D, et al. TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta. Biochim Biophys Acta, 2009, 1793(7):1165-1173.
|
5. |
Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics, 1992, 48(2):361-372.
|
6. |
Gordon KJ, Blobe GC. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta, 2008, 1782(4):197-228.
|
7. |
Chou HT, Chen CH, Tsai CH, et al. Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J, 2004, 148(1):181-186.
|
8. |
Kamal H, Hussein G, Hassoba H, et al. Transforming growth factor-beta1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt. Acta Cardiol, 2010, 65(2):177-183.
|
9. |
Ozisik K, Emir M, Ulus AT, et al. The renin-angiotensin system genetic polymorphisms and rheumatic mitral valve disease. J Heart Valve Dis, 2004,13(1):33-37.
|
10. |
Messias Reason IJ, Schafranski MD, Jensenius JC, et al. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol, 2006, 67(12):991-998.
|
11. |
Düzgün N, Duman T, Haydardedeo?lu FE, et al. Cytotoxic T lymphocyte-associated antigen-4 polymorphism in patients with rheumatic heart disease. Tissue Antigens, 2009, 74(6):539-542.
|
12. |
Hua R, Xu JB, Wang JC, et al. Association of TNFAIP3 polymorphism with rheumatic heart disease in Chinese Han population. Immunogenetics, 2009, 61(11-12):739-744.
|
13. |
Mohamed AA, Rashed LA, Shaker SM, et al. Association of tumor necrosis factor-alpha polymorphisms with susceptibility and clinical outcomes of rheumatic heart disease. Saudi Med J, 2010, 31(6):644-649.
|
14. |
Mathew S, Murty VV, Cheifetz S, et al. Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. Genomics, 1994, 20(1):114-115.
|
15. |
Jin G, Wang L, Chen W, et al. Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int J Cancer, 2007, 120(6):1330-1335.
|
16. |
Baas AF, Medic J, van’t Slot R, et al. Association of the TGF-beta receptor genes with abdominal aortic aneurysm. Eur J Hum Genet, 2010, 18(2):240-244.
|
17. |
Yun JY, Uhm YK, Kim HJ, et al. Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population. Int J Immunogenet, 2010, 37(4):289-291.
|
18. |
Lim YH, Jeong YS, Kim SK, et al. Association between TGFBR2 gene polymorphism (rs2228048, Asn389Asn) and intracerebral hemorrhage in Korean population. Immunol Invest, 2011, 40(6):569-580.
|